等待开盘 10-22 09:30:00 美东时间
-0.430
-9.75%
今日重点评级关注:Ascendiant Capital:维持PAVmed"买入"评级,目标价从19美元升至20美元;Ascendiant Capital:维持Plus Therapeutics"买入"评级,目标价从20.5美元升至21美元
10-07 15:04
LUCID CAPITAL MARKETS analyst Elemer Piros initiates coverage on Cassava Sciences (NASDAQ:SAVA) with a Buy rating and announces Price Target of $8.
10-06 20:50
Insiders have been trading these 5 stocks: (($SAVA)), (($TSE:LAC)), (($EOG)), (...
10-04 21:01
和黄医药(00013)发布公告,该公司今日宣布将于2025年10月17日至21日在德国柏林召开的欧洲肿瘤内科学会2025年年会上公布和黄医药自主研发的化合物的数...
10-02 08:14
Insiders have been trading these 5 stocks: (($SAVA)), (($TSE:CLS)), (($GTLB)), ...
09-27 21:01
WisdomTree U.S. SmallCap Quality Dividend Growth Fund (NASDAQ:DGRS) - $0.2600. Payable 09/29/2025; for shareholders of record 09/25/2025; ex-div 09/25/2025. More on Cassava Sciences: Fundamentals Upda...
09-25 22:28
中概股恒峰科技大涨35%!上市累涨逾300%;加密货币公司Bakkt再度大涨17%,公司任命新董事会成员>>
09-24 17:18
美股周二早盘,Cassava Sciences(NASDAQ:SAVA)股价上涨24.5%,此前其首席执行官Richard Barry购买了价值53474...
09-23 23:25
Cassava Sciences shares are trading higher Tuesday morning. A Form 4 filing disclosed that CEO Rick Barry acquired 237,941 shares at an average price of $2.25 each.
09-23 22:19
Cassava Sciences (NASDAQ:SAVA) president & CEO Richard Barry has disclosed a purchase of 237,941 shares of the company’s common stock in a transaction valued at around $534,743.2. The purchase was mad...
09-23 16:55